| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 3.30e-18 | 46 | 98 | 12 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.37e-10 | 188 | 98 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 2.62e-07 | 12 | 98 | 4 | GO:0048407 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 BSN COL1A2 | 4.09e-04 | 891 | 98 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | DUX4L9 NPAS3 DUX4L2 DUX4 TCF24 HIVEP3 TBX19 KLF16 HOXD4 NFATC2 FUBP1 SKOR1 ZBTB5 MAFF TBR1 OLIG1 DUX4L4 | 6.95e-04 | 1459 | 98 | 17 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | DUX4L9 NPAS3 DUX4L2 DUX4 TCF24 HIVEP3 TBX19 KLF16 HOXD4 NFATC2 SKOR1 ZBTB5 MAFF TBR1 OLIG1 DUX4L4 | 1.36e-03 | 1412 | 98 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.49e-03 | 46 | 98 | 3 | GO:0005245 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 2.31e-07 | 377 | 98 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 2.38e-07 | 378 | 98 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 2.44e-07 | 379 | 98 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 3.09e-05 | 76 | 98 | 5 | GO:0030199 | |
| GeneOntologyCellularComponent | collagen trimer | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 SFTPA2 SFTPA1 MARCO COL1A2 | 1.07e-19 | 88 | 99 | 15 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 3.67e-14 | 21 | 99 | 8 | GO:0098644 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.66e-09 | 12 | 99 | 5 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.66e-09 | 12 | 99 | 5 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 SFTPA2 CLEC14A SFTPA1 MARCO COL1A2 | 3.79e-09 | 530 | 99 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 5.67e-08 | 332 | 99 | 12 | GO:0005788 |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 SFTPA2 CLEC14A SFTPA1 MARCO COL1A2 | 7.42e-08 | 656 | 99 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 SFTPA2 CLEC14A SFTPA1 MARCO COL1A2 | 7.74e-08 | 658 | 99 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | collagen type IV trimer | 2.04e-06 | 6 | 99 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 5.67e-06 | 8 | 99 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 5.67e-06 | 8 | 99 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 5.67e-06 | 8 | 99 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type IX trimer | 1.32e-04 | 4 | 99 | 2 | GO:0005594 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 2.20e-04 | 5 | 99 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | basement membrane | 2.88e-04 | 122 | 99 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 3.29e-04 | 6 | 99 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | EKC/KEOPS complex | 4.59e-04 | 7 | 99 | 2 | GO:0000408 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.03e-03 | 42 | 99 | 3 | GO:0070971 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.35e-03 | 46 | 99 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | chromatin | SFPQ NPAS3 TSPY26P TAF6L TBX19 KLF16 SF3B1 PIAS3 HOXD4 NFATC2 ZMIZ2 ZBTB5 SMARCC2 MAFF TBR1 OLIG1 | 1.54e-03 | 1480 | 99 | 16 | GO:0000785 |
| HumanPheno | Arterial rupture | 1.12e-05 | 8 | 31 | 3 | HP:0025019 | |
| HumanPheno | Osteoarthritis | 3.81e-05 | 65 | 31 | 5 | HP:0002758 | |
| HumanPheno | Retinal detachment | 6.24e-05 | 118 | 31 | 6 | HP:0000541 | |
| Domain | Collagen | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 SFTPA2 SFTPA1 MARCO COL1A2 | 8.45e-20 | 85 | 91 | 15 | IPR008160 |
| Domain | Collagen | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 SFTPA2 SFTPA1 MARCO COL1A2 | 8.45e-20 | 85 | 91 | 15 | PF01391 |
| Domain | Fib_collagen_C | 1.11e-09 | 11 | 91 | 5 | IPR000885 | |
| Domain | COLFI | 1.11e-09 | 11 | 91 | 5 | PF01410 | |
| Domain | NC1_FIB | 1.11e-09 | 11 | 91 | 5 | PS51461 | |
| Domain | Fib_collagen_C | 1.11e-09 | 11 | 91 | 5 | PD002078 | |
| Domain | COLFI | 1.11e-09 | 11 | 91 | 5 | SM00038 | |
| Domain | TSPN | 7.71e-08 | 23 | 91 | 5 | SM00210 | |
| Domain | C4 | 2.21e-06 | 6 | 91 | 3 | SM00111 | |
| Domain | - | 2.21e-06 | 6 | 91 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.21e-06 | 6 | 91 | 3 | IPR001442 | |
| Domain | C4 | 2.21e-06 | 6 | 91 | 3 | PF01413 | |
| Domain | NC1_IV | 2.21e-06 | 6 | 91 | 3 | PS51403 | |
| Domain | Laminin_G | 9.18e-06 | 58 | 91 | 5 | IPR001791 | |
| Domain | CTDL_fold | 1.38e-05 | 107 | 91 | 6 | IPR016187 | |
| Domain | zf-MIZ | 4.85e-04 | 7 | 91 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 4.85e-04 | 7 | 91 | 2 | PS51044 | |
| Domain | Znf_MIZ | 6.45e-04 | 8 | 91 | 2 | IPR004181 | |
| Domain | VDCCAlpha1 | 1.03e-03 | 10 | 91 | 2 | IPR002077 | |
| Domain | p53-like_TF_DNA-bd | 2.20e-03 | 53 | 91 | 3 | IPR008967 | |
| Domain | TF_T-box | 3.04e-03 | 17 | 91 | 2 | IPR001699 | |
| Domain | TBOX | 3.04e-03 | 17 | 91 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 3.04e-03 | 17 | 91 | 2 | IPR018186 | |
| Domain | - | 3.04e-03 | 17 | 91 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 3.04e-03 | 17 | 91 | 2 | PS50252 | |
| Domain | T-box | 3.04e-03 | 17 | 91 | 2 | PF00907 | |
| Domain | TBOX_1 | 3.04e-03 | 17 | 91 | 2 | PS01283 | |
| Domain | TBOX_2 | 3.04e-03 | 17 | 91 | 2 | PS01264 | |
| Domain | ConA-like_dom | 4.35e-03 | 219 | 91 | 5 | IPR013320 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 7.24e-19 | 44 | 66 | 12 | M27812 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL22A1 COL23A1 COL1A2 | 2.79e-17 | 41 | 66 | 11 | MM15538 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.90e-16 | 67 | 66 | 12 | M26999 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL22A1 COL23A1 COL1A2 | 3.44e-15 | 61 | 66 | 11 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 7.99e-15 | 90 | 66 | 12 | M631 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL22A1 COL23A1 COL1A2 | 4.47e-14 | 76 | 66 | 11 | MM14573 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL23A1 COL1A2 | 3.09e-13 | 64 | 66 | 10 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL27A1 COL1A2 | 8.79e-12 | 61 | 66 | 9 | M27103 |
| Pathway | PID_SYNDECAN_1_PATHWAY | 3.38e-11 | 46 | 66 | 8 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.85e-11 | 50 | 66 | 8 | MM14796 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.09e-10 | 32 | 66 | 7 | MM14924 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL16A1 COL23A1 COL1A2 | 1.91e-10 | 85 | 66 | 9 | M16441 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.07e-10 | 20 | 66 | 6 | MM15061 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 8.43e-10 | 42 | 66 | 7 | M7169 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL23A1 COL1A2 | 8.87e-10 | 140 | 66 | 10 | M587 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.76e-09 | 74 | 66 | 8 | M160 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.19e-09 | 76 | 66 | 8 | MM14867 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.63e-09 | 53 | 66 | 7 | MM14566 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.00e-08 | 59 | 66 | 7 | M27218 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.22e-08 | 300 | 66 | 12 | M610 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.60e-08 | 63 | 66 | 7 | M11187 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.05e-08 | 38 | 66 | 6 | MM14969 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 2.13e-08 | 19 | 66 | 5 | M27221 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL22A1 COL23A1 COL1A2 | 2.75e-08 | 258 | 66 | 11 | MM14572 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.03e-08 | 76 | 66 | 7 | M27219 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.21e-07 | 84 | 66 | 7 | M7098 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.51e-07 | 30 | 66 | 5 | M27772 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.51e-07 | 57 | 66 | 6 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.79e-07 | 58 | 66 | 6 | M2049 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 5.75e-07 | 15 | 66 | 4 | M27161 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 6.09e-07 | 66 | 66 | 6 | M18 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 9.87e-07 | 114 | 66 | 7 | MM14571 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.27e-06 | 41 | 66 | 5 | M27778 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.28e-06 | 18 | 66 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.28e-06 | 18 | 66 | 4 | MM14882 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.61e-06 | 19 | 66 | 4 | MM15512 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.62e-06 | 43 | 66 | 5 | M39565 | |
| Pathway | WP_FOCAL_ADHESION | 2.46e-06 | 187 | 66 | 8 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.90e-06 | 199 | 66 | 8 | M7253 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.10e-05 | 30 | 66 | 4 | MM15517 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.15e-05 | 10 | 66 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.15e-05 | 10 | 66 | 3 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.57e-05 | 11 | 66 | 3 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.09e-05 | 12 | 66 | 3 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.71e-05 | 13 | 66 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.71e-05 | 13 | 66 | 3 | M12950 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.33e-05 | 79 | 66 | 5 | M27643 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.44e-05 | 14 | 66 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.44e-05 | 14 | 66 | 3 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.28e-05 | 15 | 66 | 3 | MM14922 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.72e-05 | 47 | 66 | 4 | MM14925 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 9.36e-05 | 98 | 66 | 5 | M27152 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.06e-04 | 20 | 66 | 3 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.62e-04 | 23 | 66 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.62e-04 | 23 | 66 | 3 | MM1427 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.11e-04 | 261 | 66 | 7 | MM15676 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.65e-04 | 27 | 66 | 3 | M27217 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.69e-04 | 67 | 66 | 4 | MM15345 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 2.95e-04 | 28 | 66 | 3 | MM15957 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.64e-04 | 30 | 66 | 3 | M27216 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.10e-04 | 302 | 66 | 7 | M39719 | |
| Pathway | REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5 | 5.94e-04 | 8 | 66 | 2 | M27575 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 6.38e-04 | 84 | 66 | 4 | M3228 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 7.12e-04 | 418 | 66 | 8 | MM15587 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL27A1 COL1A2 | 7.90e-04 | 532 | 66 | 9 | M27870 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.02e-04 | 326 | 66 | 7 | MM15917 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM | 9.48e-04 | 10 | 66 | 2 | M27573 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.06e-03 | 43 | 66 | 3 | M53 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 CACNA1I VASP AGAP2 | 1.36e-03 | 575 | 66 | 9 | M29853 |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 1.89e-03 | 14 | 66 | 2 | MM15011 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 2.29e-03 | 502 | 66 | 8 | MM14537 | |
| Pathway | WP_FOCAL_ADHESION | 2.37e-03 | 199 | 66 | 5 | M39402 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 2.48e-03 | 16 | 66 | 2 | M925 | |
| Pathway | WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME | 2.91e-03 | 61 | 66 | 3 | M48077 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 3.15e-03 | 18 | 66 | 2 | M39421 | |
| Pathway | PID_AP1_PATHWAY | 4.29e-03 | 70 | 66 | 3 | M167 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 4.69e-03 | 22 | 66 | 2 | M27571 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 4.69e-03 | 22 | 66 | 2 | MM15284 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 5.13e-03 | 23 | 66 | 2 | MM15279 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 5.13e-03 | 23 | 66 | 2 | M47666 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 DUX4 PABPN1L CACNG8 HOXD4 SMARCC2 CACNA1I VASP AGAP2 | 5.76e-03 | 1432 | 66 | 14 | M509 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 6.04e-03 | 25 | 66 | 2 | M47948 | |
| Pubmed | 2.58e-18 | 12 | 105 | 8 | 10433963 | ||
| Pubmed | 6.68e-18 | 13 | 105 | 8 | 17668377 | ||
| Pubmed | The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. | 1.49e-17 | 8 | 105 | 7 | 17588759 | |
| Pubmed | 2.22e-16 | 10 | 105 | 7 | 17984056 | ||
| Pubmed | 3.15e-15 | 13 | 105 | 7 | 7739628 | ||
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL16A1 COL27A1 COL23A1 SFTPA2 CLEC14A SFTPA1 COL1A2 | 4.28e-15 | 167 | 105 | 13 | 22159717 | |
| Pubmed | Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. | 3.54e-14 | 17 | 105 | 7 | 11245978 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.55e-11 | 62 | 105 | 8 | 28344315 | |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL11A2 COL16A1 COL27A1 COL22A1 COL1A2 | 1.53e-10 | 175 | 105 | 10 | 28071719 | |
| Pubmed | 9.69e-10 | 16 | 105 | 5 | 17881772 | ||
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL16A1 COL23A1 COL1A2 | 1.02e-09 | 153 | 105 | 9 | 25037231 | |
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 5.44e-09 | 8 | 105 | 4 | 11867580 | |
| Pubmed | 9.77e-09 | 9 | 105 | 4 | 9878537 | ||
| Pubmed | 9.77e-09 | 9 | 105 | 4 | 8900172 | ||
| Pubmed | 1.15e-08 | 25 | 105 | 5 | 19180518 | ||
| Pubmed | 1.62e-08 | 10 | 105 | 4 | 9415455 | ||
| Pubmed | 1.62e-08 | 10 | 105 | 4 | 2446864 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 34691289 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 1.04e-07 | 15 | 105 | 4 | 9832566 | |
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 1.07e-07 | 4 | 105 | 3 | 7827955 | |
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 12874293 | ||
| Pubmed | The homeobox transcription factor DUXBL controls exit from totipotency. | 1.07e-07 | 4 | 105 | 3 | 38509386 | |
| Pubmed | Whole-exome sequencing of Finnish patients with vascular cognitive impairment. | 1.07e-07 | 4 | 105 | 3 | 33268848 | |
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 17911620 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.88e-07 | 135 | 105 | 7 | 28675934 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.53e-07 | 86 | 105 | 6 | 28327460 | |
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 9409248 | ||
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 20063414 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 2.66e-07 | 5 | 105 | 3 | 14758483 | |
| Pubmed | 2.94e-07 | 19 | 105 | 4 | 15689378 | ||
| Pubmed | 4.33e-07 | 50 | 105 | 5 | 23658023 | ||
| Pubmed | 4.51e-07 | 21 | 105 | 4 | 27856617 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 5.31e-07 | 6 | 105 | 3 | 9506531 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 7495302 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 5.31e-07 | 6 | 105 | 3 | 17029294 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 5.31e-07 | 6 | 105 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 5.31e-07 | 6 | 105 | 3 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 5.31e-07 | 6 | 105 | 3 | 6389236 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 16192629 | ||
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 5.31e-07 | 6 | 105 | 3 | 10534397 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 10722718 | ||
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 9101290 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 5.31e-07 | 6 | 105 | 3 | 9673377 | |
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 5.31e-07 | 6 | 105 | 3 | 3571333 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 5.31e-07 | 6 | 105 | 3 | 19275937 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 6988303 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 10639489 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 9.28e-07 | 7 | 105 | 3 | 8006028 | |
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 10416788 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 23273220 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 9.28e-07 | 7 | 105 | 3 | 10716744 | |
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 1724753 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 7521231 | ||
| Pubmed | The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection. | 9.28e-07 | 7 | 105 | 3 | 30765463 | |
| Pubmed | ARID3A TRIP6 DUX4L9 DUX4L2 HIVEP3 TBX19 KLF16 PIAS3 ZMIZ2 ZBTB5 OLIG1 DUX4L4 ZNF687 | 1.02e-06 | 808 | 105 | 13 | 20412781 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.11e-06 | 26 | 105 | 4 | 34189436 | |
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 1.48e-06 | 8 | 105 | 3 | 9382709 | |
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 3997552 | ||
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 29422532 | ||
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 1377218 | ||
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 18816857 | ||
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 10382266 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 8562707 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 10880400 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 8995276 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 12101409 | ||
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 14559231 | ||
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 9136074 | ||
| Pubmed | 3.65e-06 | 210 | 105 | 7 | 16537572 | ||
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 4.33e-06 | 11 | 105 | 3 | 7500359 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 4.33e-06 | 11 | 105 | 3 | 9731539 | |
| Pubmed | 5.64e-06 | 146 | 105 | 6 | 27068509 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 5.77e-06 | 12 | 105 | 3 | 12180907 | |
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 23740775 | ||
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 5.77e-06 | 12 | 105 | 3 | 15837576 | |
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 16024816 | ||
| Pubmed | 5.95e-06 | 39 | 105 | 4 | 33580754 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 7.48e-06 | 13 | 105 | 3 | 9833687 | |
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 7.48e-06 | 13 | 105 | 3 | 11839810 | |
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 7.48e-06 | 13 | 105 | 3 | 21173153 | |
| Pubmed | Major Effect of Oxidative Stress on the Male, but Not Female, SP-A1 Type II Cell miRNome. | 9.03e-06 | 2 | 105 | 2 | 31354704 | |
| Pubmed | Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4. | 9.03e-06 | 2 | 105 | 2 | 35444643 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17179069 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 32515830 | ||
| Pubmed | Sequence variants in COL4A1 and COL4A2 genes in Ecuadorian families with keratoconus. | 9.03e-06 | 2 | 105 | 2 | 21527998 | |
| Pubmed | Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. | 9.03e-06 | 2 | 105 | 2 | 10749762 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 39216230 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17593964 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25169943 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 24317722 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 2610270 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31331924 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9922219 | ||
| Pubmed | Maternal surfactant protein A influences the immunoprotective properties of milk in a murine model. | 9.03e-06 | 2 | 105 | 2 | 24858142 | |
| Interaction | CD93 interactions | 6.57e-08 | 45 | 95 | 6 | int:CD93 | |
| Interaction | LAIR2 interactions | 3.39e-06 | 49 | 95 | 5 | int:LAIR2 | |
| Interaction | TGFBI interactions | 5.43e-06 | 25 | 95 | 4 | int:TGFBI | |
| Interaction | MAG interactions | 1.01e-05 | 29 | 95 | 4 | int:MAG | |
| Interaction | PDGFA interactions | 1.51e-05 | 32 | 95 | 4 | int:PDGFA | |
| Interaction | MMP9 interactions | 1.60e-05 | 67 | 95 | 5 | int:MMP9 | |
| Interaction | PLOD3 interactions | 2.56e-05 | 183 | 95 | 7 | int:PLOD3 | |
| Interaction | DCN interactions | 4.97e-05 | 43 | 95 | 4 | int:DCN | |
| Interaction | C1QTNF1 interactions | 7.08e-05 | 47 | 95 | 4 | int:C1QTNF1 | |
| Interaction | HABP2 interactions | 7.87e-05 | 18 | 95 | 3 | int:HABP2 | |
| Interaction | OSM interactions | 1.09e-04 | 20 | 95 | 3 | int:OSM | |
| Cytoband | 4q35.2 | 3.53e-11 | 27 | 105 | 6 | 4q35.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q35 | 3.17e-10 | 117 | 105 | 8 | chr4q35 | |
| Cytoband | 11q13.2 | 1.75e-04 | 47 | 105 | 3 | 11q13.2 | |
| GeneFamily | Collagens | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 5.94e-19 | 46 | 78 | 12 | 490 |
| GeneFamily | PRD class homeoboxes and pseudogenes | 1.38e-07 | 92 | 78 | 7 | 521 | |
| GeneFamily | CTAGE family | 3.39e-05 | 15 | 78 | 3 | 907 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.87e-04 | 26 | 78 | 3 | 253 | |
| GeneFamily | Zinc fingers MIZ-type | 3.80e-04 | 7 | 78 | 2 | 85 | |
| GeneFamily | Collectins | 8.09e-04 | 10 | 78 | 2 | 491 | |
| GeneFamily | T-boxes | 2.69e-03 | 18 | 78 | 2 | 766 | |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 9.70e-20 | 43 | 103 | 12 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.33e-19 | 44 | 103 | 12 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 7.44e-10 | 270 | 103 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 9.17e-10 | 275 | 103 | 12 | M5884 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.70e-08 | 23 | 103 | 5 | M48001 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP | 1.91e-06 | 147 | 103 | 7 | M2989 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL3A1 COL4A1 COL4A2 COL5A1 COL27A1 NPAS3 MCTP1 CLEC14A NOTCH3 ZNF687 COL1A2 | 4.93e-06 | 505 | 103 | 11 | M39167 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.95e-06 | 29 | 103 | 4 | MM17055 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS | 5.72e-06 | 113 | 103 | 6 | M43610 | |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 SFTPA2 CLEC14A SFTPA1 COL1A2 | 9.26e-06 | 1008 | 103 | 15 | MM17056 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | COL4A1 COL4A2 COL9A3 ARID3A MYOZ3 TSPY26P KCNH6 MCTP1 PIAS3 CACNA1I SRRM3 ZMYM3 NOTCH3 COL1A2 | 1.03e-05 | 891 | 103 | 14 | M45033 |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.07e-05 | 126 | 103 | 6 | M39132 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.10e-05 | 74 | 103 | 5 | M13547 | |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 SFTPA2 CLEC14A SFTPA1 COL1A2 | 1.14e-05 | 1026 | 103 | 15 | M5889 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | COL11A2 GAS1 LMTK2 DUX4 TAF6L ZMIZ2 DYRK1B CACNA1I DUX4L5 DUX4L6 DUX4L4 DUX4L7 HSD17B8 NOTCH3 | 1.29e-05 | 909 | 103 | 14 | M41018 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.45e-05 | 200 | 103 | 7 | M5930 | |
| Coexpression | CHANG_POU5F1_TARGETS_UP | 2.59e-05 | 15 | 103 | 3 | M9138 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 2.59e-05 | 15 | 103 | 3 | MM402 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 3.83e-05 | 48 | 103 | 4 | M10253 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 3.83e-05 | 48 | 103 | 4 | MM1088 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.85e-05 | 17 | 103 | 3 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.85e-05 | 17 | 103 | 3 | M2223 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 4.43e-05 | 162 | 103 | 6 | M45037 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN | 5.42e-05 | 168 | 103 | 6 | M2991 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 5.45e-05 | 19 | 103 | 3 | M15125 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 7.67e-05 | 352 | 103 | 8 | M17471 | |
| Coexpression | BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN | 1.05e-04 | 118 | 103 | 5 | M34005 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.20e-04 | 194 | 103 | 6 | M39122 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.42e-04 | 385 | 103 | 8 | M39264 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.60e-04 | 69 | 103 | 4 | M10165 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.79e-04 | 71 | 103 | 4 | M3955 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL3A1 COL4A1 COL4A2 COL5A1 COL16A1 GAS1 HOXD4 AMOTL2 ENPEP NOTCH3 COL1A2 | 2.17e-04 | 767 | 103 | 11 | M39209 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 2.27e-04 | 6 | 103 | 2 | M48000 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 2.41e-04 | 141 | 103 | 5 | M10381 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.69e-04 | 79 | 103 | 4 | M18400 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 2.83e-04 | 146 | 103 | 5 | MM973 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.83e-04 | 80 | 103 | 4 | MM1285 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 2.95e-04 | 33 | 103 | 3 | M9167 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.97e-04 | 81 | 103 | 4 | M39253 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 3.40e-04 | 438 | 103 | 8 | M1954 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 3.50e-04 | 440 | 103 | 8 | MM832 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.52e-04 | 35 | 103 | 3 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.52e-04 | 35 | 103 | 3 | M11788 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 3.73e-04 | 86 | 103 | 4 | M2259 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.83e-04 | 36 | 103 | 3 | MM1212 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 4.43e-04 | 90 | 103 | 4 | M38984 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 4.69e-04 | 163 | 103 | 5 | M2769 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 9.31e-07 | 74 | 94 | 6 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | BM Top 100 - endometrium | 1.10e-05 | 66 | 94 | 5 | BM Top 100 - endometrium | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 4.20e-05 | 143 | 94 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A4 COL5A1 COL16A1 GAS1 ENPEP NOTCH3 COL1A2 | 4.62e-10 | 191 | 99 | 9 | b7a57691a4742070cee640e285c1f4d0da95baf1 |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A2 COL5A1 SFPQ COL11A2 COL16A1 NFATC2 COL1A2 | 5.30e-10 | 194 | 99 | 9 | e3d63874111d1e8da3977329426e4dcf68d6de87 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL16A1 COL27A1 NFATC2 COL1A2 | 6.07e-10 | 197 | 99 | 9 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL16A1 COL27A1 NFATC2 COL1A2 | 6.07e-10 | 197 | 99 | 9 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-09 | 176 | 99 | 8 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-09 | 176 | 99 | 8 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 9.90e-09 | 188 | 99 | 8 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-08 | 195 | 99 | 8 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.37e-08 | 196 | 99 | 8 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-08 | 197 | 99 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-08 | 198 | 99 | 8 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-08 | 198 | 99 | 8 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-08 | 198 | 99 | 8 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-08 | 198 | 99 | 8 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-08 | 198 | 99 | 8 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-08 | 199 | 99 | 8 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-08 | 199 | 99 | 8 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.60e-08 | 200 | 99 | 8 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.60e-08 | 200 | 99 | 8 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-08 | 200 | 99 | 8 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.00e-08 | 156 | 99 | 7 | fe383ce3a0c37f7343d7026cb51260a04d4c2829 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-07 | 177 | 99 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-07 | 177 | 99 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.65e-07 | 181 | 99 | 7 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.72e-07 | 182 | 99 | 7 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.99e-07 | 186 | 99 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-07 | 188 | 99 | 7 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.22e-07 | 189 | 99 | 7 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.22e-07 | 189 | 99 | 7 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.30e-07 | 190 | 99 | 7 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-07 | 190 | 99 | 7 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.30e-07 | 190 | 99 | 7 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.30e-07 | 190 | 99 | 7 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.38e-07 | 191 | 99 | 7 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.38e-07 | 191 | 99 | 7 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.38e-07 | 191 | 99 | 7 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.56e-07 | 193 | 99 | 7 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-07 | 193 | 99 | 7 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.56e-07 | 193 | 99 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-07 | 193 | 99 | 7 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.65e-07 | 194 | 99 | 7 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 2.65e-07 | 194 | 99 | 7 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-07 | 195 | 99 | 7 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-07 | 195 | 99 | 7 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-07 | 195 | 99 | 7 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.74e-07 | 195 | 99 | 7 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-07 | 195 | 99 | 7 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-07 | 195 | 99 | 7 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.84e-07 | 196 | 99 | 7 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.84e-07 | 196 | 99 | 7 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-07 | 196 | 99 | 7 | acbb493dbb49a33f20cf11106363f7ed51209706 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.84e-07 | 196 | 99 | 7 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-07 | 196 | 99 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-07 | 196 | 99 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-07 | 196 | 99 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-07 | 196 | 99 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.84e-07 | 196 | 99 | 7 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.84e-07 | 196 | 99 | 7 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.84e-07 | 196 | 99 | 7 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.84e-07 | 196 | 99 | 7 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | MatrixFB|World / shred on cell class and cell subclass (v4) | 2.94e-07 | 197 | 99 | 7 | e325de44e32021a36fffb7b7e88167b46bb051c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-07 | 197 | 99 | 7 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-07 | 197 | 99 | 7 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-07 | 197 | 99 | 7 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-07 | 197 | 99 | 7 | af819b0561c8db582c5b466d804153d69d3297e0 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-07 | 197 | 99 | 7 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-07 | 197 | 99 | 7 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-07 | 197 | 99 | 7 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.94e-07 | 197 | 99 | 7 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-07 | 197 | 99 | 7 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-07 | 197 | 99 | 7 | 4a04da876a1482604452ae53c124ae68eda0bd5e | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 2.94e-07 | 197 | 99 | 7 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-07 | 197 | 99 | 7 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.94e-07 | 197 | 99 | 7 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-07 | 197 | 99 | 7 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-07 | 198 | 99 | 7 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-07 | 198 | 99 | 7 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-07 | 198 | 99 | 7 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.14e-07 | 199 | 99 | 7 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.14e-07 | 199 | 99 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 3.14e-07 | 199 | 99 | 7 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.14e-07 | 199 | 99 | 7 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-07 | 199 | 99 | 7 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.14e-07 | 199 | 99 | 7 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.14e-07 | 199 | 99 | 7 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-07 | 200 | 99 | 7 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-07 | 200 | 99 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Lung_Parenchyma|World / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.36e-07 | 201 | 99 | 7 | 91ec5eebe93a3c7b1a33c27e5da949b123b676a8 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-07 | 127 | 99 | 6 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.26e-06 | 154 | 99 | 6 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 155 | 99 | 6 | 82e602f31981c6b48abff2a04b2ab5d26d4462a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 155 | 99 | 6 | 979c1d53b435a82c57d16707eed8ba7346326866 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.46e-06 | 158 | 99 | 6 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 159 | 99 | 6 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.51e-06 | 159 | 99 | 6 | 7a5c94c87b73f928d4daee507f32cbe7d90e4478 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.51e-06 | 159 | 99 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 159 | 99 | 6 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-06 | 162 | 99 | 6 | c5eee02836efde2108534679850c28d2b2cfce3f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.75e-06 | 163 | 99 | 6 | b0aa4a620bd58011225b42ea6dda04e3101ba342 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.81e-06 | 164 | 99 | 6 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| Computational | ECM and collagens. | 1.95e-05 | 225 | 56 | 8 | MODULE_47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.27e-04 | 50 | 56 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Neighborhood of CDH11 | 2.84e-04 | 25 | 56 | 3 | GNF2_CDH11 | |
| Computational | Ovary genes. | 5.90e-04 | 368 | 56 | 8 | MODULE_1 | |
| Computational | Adhesion molecules. | 8.07e-04 | 141 | 56 | 5 | MODULE_122 | |
| Computational | Neighborhood of PTX3 | 8.47e-04 | 36 | 56 | 3 | GNF2_PTX3 | |
| Drug | GK-101 | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 4.78e-16 | 36 | 102 | 10 | CID000161853 |
| Drug | Madecassol | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 7.39e-15 | 46 | 102 | 10 | CID000108062 |
| Drug | d-indobufen | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.83e-14 | 50 | 102 | 10 | CID000044562 |
| Drug | ridogrel | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 2.80e-14 | 52 | 102 | 10 | CID005362391 |
| Drug | NSC49633 | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 3.44e-14 | 53 | 102 | 10 | CID000023340 |
| Drug | AC1LAKND | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.84e-13 | 62 | 102 | 10 | CID000470146 |
| Drug | Selara | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 NANOS1 VASP COL1A2 | 3.90e-13 | 125 | 102 | 12 | CID000150310 |
| Drug | malotilate | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 7.63e-13 | 71 | 102 | 10 | CID000004006 |
| Drug | BAPN | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 7.63e-13 | 71 | 102 | 10 | CID000001647 |
| Drug | AC1NMZ1B | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.35e-12 | 75 | 102 | 10 | CID005034185 |
| Drug | strontium ranelate | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.77e-12 | 77 | 102 | 10 | CID006918182 |
| Drug | AC1L1C2F | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 AGAP2 COL1A2 | 2.48e-12 | 110 | 102 | 11 | CID000001711 |
| Drug | halofuginone lactate | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 4.91e-12 | 85 | 102 | 10 | CID000062891 |
| Drug | 4-hydroxyproline | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 9.87e-12 | 91 | 102 | 10 | CID000000825 |
| Drug | DL-penicillamine | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 NANOS1 COL1A2 | 3.26e-11 | 139 | 102 | 11 | CID000004727 |
| Drug | PCR 4099 | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 VASP COL1A2 | 3.26e-11 | 139 | 102 | 11 | CID000002806 |
| Drug | ticlopidine | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 3.47e-11 | 103 | 102 | 10 | CID000005472 |
| Drug | hydroxylysine | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 6.13e-11 | 109 | 102 | 10 | CID000001029 |
| Drug | PPACK | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 8.79e-11 | 113 | 102 | 10 | CID003036757 |
| Drug | AC1L9732 | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 9.60e-11 | 114 | 102 | 10 | CID000439300 |
| Drug | Tranilast sodium | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.05e-10 | 115 | 102 | 10 | CID000005527 |
| Drug | DMSe | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 4.12e-10 | 132 | 102 | 10 | CID000020796 |
| Drug | pirfenidone | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 6.38e-10 | 138 | 102 | 10 | CID000040632 |
| Drug | foscarnet | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 BSN COL1A2 | 9.41e-10 | 190 | 102 | 11 | CID000003414 |
| Drug | candesartan cilexetil | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.04e-09 | 145 | 102 | 10 | CID000002540 |
| Drug | prostacyclin sodium salt | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 NANOS1 VASP COL1A2 | 1.33e-09 | 250 | 102 | 12 | CID000000159 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 3.05e-09 | 162 | 102 | 10 | CID000072363 |
| Drug | khellin | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 5.15e-09 | 171 | 102 | 10 | CID000003828 |
| Drug | AC1Q6PCP | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 CACNA1I COL1A2 | 7.00e-09 | 230 | 102 | 11 | CID000005267 |
| Drug | AC1L1DD6 | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 8.00e-09 | 179 | 102 | 10 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.35e-08 | 189 | 102 | 10 | CID000001413 |
| Drug | AC1L18QD | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 NANOS1 VASP COL1A2 | 2.51e-08 | 325 | 102 | 12 | CID000000213 |
| Drug | L-3,4-dehydroproline | 3.76e-08 | 73 | 102 | 7 | CID000094284 | |
| Drug | silibinin | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 ENPEP COL1A2 | 6.34e-08 | 285 | 102 | 11 | CID000005213 |
| Drug | losartan | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 NANOS1 ENPEP COL1A2 | 1.30e-07 | 378 | 102 | 12 | CID000003961 |
| Drug | colchine | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 BSN NANOS1 COL1A2 | 1.50e-07 | 383 | 102 | 12 | CID000002833 |
| Drug | hyaluronan | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 2.99e-07 | 263 | 102 | 10 | CID000024759 |
| Drug | isodesmosine | 3.51e-07 | 33 | 102 | 5 | CID000013811 | |
| Drug | Y-27632 | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 NANOS1 VASP COL1A2 | 7.22e-07 | 444 | 102 | 12 | CID000005711 |
| Drug | PD123177 | 1.37e-06 | 43 | 102 | 5 | CID000114899 | |
| Drug | aspirin | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 CTAG2 COL23A1 NANOS1 VASP COL1A2 | 1.41e-06 | 563 | 102 | 13 | CID000002244 |
| Drug | AC1L1KMJ | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 KCNH6 MARCO COL1A2 | 1.50e-06 | 476 | 102 | 12 | CID000030956 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.50e-06 | 314 | 102 | 10 | CID000447989 |
| Drug | NC-4 | 1.55e-06 | 44 | 102 | 5 | CID006420119 | |
| Drug | 351A | 1.74e-06 | 20 | 102 | 4 | CID000122144 | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.56e-06 | 193 | 102 | 8 | 3857_UP | |
| Drug | desmosine | 3.95e-06 | 53 | 102 | 5 | CID000025435 | |
| Drug | 1h00 | 5.21e-06 | 56 | 102 | 5 | CID000445950 | |
| Drug | pyridinoline | 5.58e-06 | 99 | 102 | 6 | CID000105068 | |
| Drug | trapidil | 5.69e-06 | 57 | 102 | 5 | CID000005531 | |
| Drug | LS-63783 | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 MAFF NANOS1 PCDH8 VASP COL1A2 | 1.40e-05 | 804 | 102 | 14 | CID000000231 |
| Drug | chondroitin sulfate | COL3A1 COL4A1 COL5A1 COL9A3 COL11A2 COL16A1 COL27A1 COL22A1 COL23A1 COL1A2 | 1.67e-05 | 413 | 102 | 10 | CID000024766 |
| Drug | Sirius red | 1.79e-05 | 35 | 102 | 4 | CID005486818 | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; MCF7; HT_HG-U133A | 2.73e-05 | 194 | 102 | 7 | 2753_DN | |
| Drug | AC1MRIIV | 2.77e-05 | 39 | 102 | 4 | CID003518584 | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; HL60; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 6158_UP | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 4301_UP | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 5931_UP | |
| Drug | glycyl-L-leucine | 1.01e-04 | 54 | 102 | 4 | CID000092843 | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.04e-04 | 166 | 102 | 6 | 2446_UP | |
| Drug | Collagenase | 1.19e-04 | 4 | 102 | 2 | DB00048 | |
| Drug | AC1Q641C | 1.73e-04 | 62 | 102 | 4 | CID000005005 | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.82e-04 | 184 | 102 | 6 | 2758_UP | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 2.10e-04 | 189 | 102 | 6 | 1206_DN | |
| Drug | carmustine; Down 200; 100uM; PC3; HT_HG-U133A | 2.42e-04 | 194 | 102 | 6 | 6883_DN | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; MCF7; HT_HG-U133A | 2.42e-04 | 194 | 102 | 6 | 5609_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.49e-04 | 195 | 102 | 6 | 4384_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 2.49e-04 | 195 | 102 | 6 | 5582_UP | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 3238_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 3353_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 3409_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 2.56e-04 | 196 | 102 | 6 | 490_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 6940_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 6001_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 3743_UP | |
| Drug | Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 6743_UP | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; HL60; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 2570_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 4592_DN | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HG-U133A | 2.78e-04 | 199 | 102 | 6 | 1888_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 2071_UP | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; HL60; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 1270_UP | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 7355_DN | |
| Drug | Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 2655_UP | |
| Drug | angiotensin | 2.81e-04 | 282 | 102 | 7 | CID003083715 | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.85e-04 | 200 | 102 | 6 | 3896_DN | |
| Drug | Noscapine [128-62-1]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.85e-04 | 200 | 102 | 6 | 5851_UP | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.85e-04 | 200 | 102 | 6 | 6766_UP | |
| Drug | Tomatidine [77-59-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.85e-04 | 200 | 102 | 6 | 7166_UP | |
| Drug | enzacamene | 2.90e-04 | 129 | 102 | 5 | ctd:C038939 | |
| Drug | BPAT-143 | 2.95e-04 | 6 | 102 | 2 | CID000146249 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 2.95e-04 | 6 | 102 | 2 | ctd:C502971 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.20e-06 | 9 | 89 | 3 | DOID:13359 (is_implicated_in) | |
| Disease | Developmental Porencephaly | 9.00e-06 | 2 | 89 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 9.00e-06 | 2 | 89 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 9.00e-06 | 2 | 89 | 2 | C0302892 | |
| Disease | Porencephaly | 9.00e-06 | 2 | 89 | 2 | C4082173 | |
| Disease | PORENCEPHALY, FAMILIAL | 9.00e-06 | 2 | 89 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 9.00e-06 | 2 | 89 | 2 | C3281105 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 9.00e-06 | 2 | 89 | 2 | C4551998 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.02e-05 | 53 | 89 | 4 | C4707243 | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 2.69e-05 | 3 | 89 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 2.69e-05 | 3 | 89 | 2 | 614519 | |
| Disease | level of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum | 8.94e-05 | 5 | 89 | 2 | OBA_2042200 | |
| Disease | level of prosaposin in blood serum | 8.94e-05 | 5 | 89 | 2 | OBA_2044552 | |
| Disease | Ehlers-Danlos Syndrome | 8.94e-05 | 5 | 89 | 2 | C0013720 | |
| Disease | newborn respiratory distress syndrome (biomarker_via_orthology) | 1.34e-04 | 6 | 89 | 2 | DOID:12716 (biomarker_via_orthology) | |
| Disease | newborn respiratory distress syndrome (is_implicated_in) | 1.87e-04 | 7 | 89 | 2 | DOID:12716 (is_implicated_in) | |
| Disease | Tinnitus, wellbeing measurement | 2.08e-04 | 96 | 89 | 4 | EFO_0007869, HP_0000360 | |
| Disease | Ehlers-Danlos syndrome | 2.49e-04 | 8 | 89 | 2 | cv:C0013720 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 2.49e-04 | 8 | 89 | 2 | EFO_0801768 | |
| Disease | intracranial aneurysm (is_implicated_in) | 5.82e-04 | 12 | 89 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 5.82e-04 | 12 | 89 | 2 | EFO_0801493 | |
| Disease | collagen disease (implicated_via_orthology) | 5.82e-04 | 12 | 89 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | granulins measurement | 5.82e-04 | 12 | 89 | 2 | EFO_0008141 | |
| Disease | Tinnitus | 6.58e-04 | 130 | 89 | 4 | HP_0000360 | |
| Disease | Connective Tissue Diseases | 6.87e-04 | 13 | 89 | 2 | C0009782 | |
| Disease | Migraine Disorders | 6.87e-04 | 13 | 89 | 2 | C0149931 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 6.87e-04 | 13 | 89 | 2 | C0238288 | |
| Disease | Impaired cognition | 8.00e-04 | 14 | 89 | 2 | C0338656 | |
| Disease | Hamman-Rich syndrome | 8.00e-04 | 14 | 89 | 2 | C0085786 | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 8.00e-04 | 14 | 89 | 2 | DOID:874 (biomarker_via_orthology) | |
| Disease | Cerebrovascular accident | 8.82e-04 | 62 | 89 | 3 | C0038454 | |
| Disease | non-lobar intracerebral hemorrhage | 9.24e-04 | 63 | 89 | 3 | EFO_0010178 | |
| Disease | arterial stiffness measurement | 9.68e-04 | 64 | 89 | 3 | EFO_0004517 | |
| Disease | Lewy body measurement, Parkinson disease | 1.05e-03 | 16 | 89 | 2 | EFO_0007021, MONDO_0005180 | |
| Disease | Dementia | 1.19e-03 | 17 | 89 | 2 | C0497327 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.49e-03 | 19 | 89 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 1.65e-03 | 20 | 89 | 2 | C4721952 | |
| Disease | Idiopathic Pulmonary Fibrosis | 1.82e-03 | 21 | 89 | 2 | C1800706 | |
| Disease | Liver Cirrhosis, Experimental | 2.36e-03 | 774 | 89 | 8 | C0023893 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 2.38e-03 | 24 | 89 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | macula measurement | 2.61e-03 | 189 | 89 | 4 | EFO_0008375 | |
| Disease | Nephrotic Syndrome | 3.01e-03 | 27 | 89 | 2 | C0027726 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PHAGDRDPRGAPGGS | 126 | Q9Y2J4 | |
| PGSRGAPFPHSGLQG | 241 | A6NDY0 | |
| GPPHGGLGTRFSGRG | 86 | Q5T6M2 | |
| AGHRGSAGALGPQGP | 381 | Q14050 | |
| PRGGAPRGPHGGAAS | 56 | O75638 | |
| ARASGPGGGAPRGPH | 51 | P78358 | |
| PGGGAPRGPHGGAAS | 56 | P78358 | |
| GGGRGPSSPGNPLDH | 556 | Q8IX94 | |
| GGGRGPSSPGNPLDH | 556 | P0CG41 | |
| GGGRGPSSPGNPLDH | 556 | A4FU28 | |
| SATHGGGSPPGTRGP | 106 | P46379 | |
| GGSPPGTRGPGASVH | 111 | P46379 | |
| HPGGPPVSGTLQGAG | 516 | P46379 | |
| AGERGHPGAPGPSGS | 1406 | Q07092 | |
| GGLCSAAPGGGHPAP | 161 | P0CJ87 | |
| GRSHPGGPGSPRGGG | 151 | Q96PG8 | |
| PGPQGAPGLSGSDGH | 691 | P53420 | |
| GSSGPPGPAGATGRA | 1236 | P53420 | |
| GFPGSPGSDIHGDPG | 1206 | P08572 | |
| EGRTGGGVPGSSSPH | 156 | Q99490 | |
| GGLCSAAPGGGHPAP | 161 | P0CJ89 | |
| PGGRRAGEPGHSPAD | 386 | Q9Y463 | |
| GLSPHPEGGPGSGRL | 311 | C9JTQ0 | |
| GRAGSPGRDGHPGLP | 556 | P02462 | |
| GDHGFPGSSGPRGDP | 906 | P02462 | |
| GSGPPGLGSAPGHLG | 806 | Q9NTZ6 | |
| HRPGAEGSPGGEASP | 371 | Q9HCC9 | |
| EQGPGRPGDAPHTGG | 181 | O60840 | |
| RPGDAPHTGGKPGGF | 186 | O60840 | |
| DGGDAPGHEPGGSPQ | 11 | Q13469 | |
| HRGRPGPEGAGPAAG | 26 | Q9BXK1 | |
| GAAGGTPPGGRSPDS | 141 | Q6DN14 | |
| SGSGPAHGPDPAHGP | 146 | Q9ULX9 | |
| GGLCSAAPGGGHPAP | 161 | Q9UBX2 | |
| GRPAPGFHHGDGPGN | 171 | Q96AE4 | |
| SEGSHGRPGGPGPGT | 156 | Q9H252 | |
| AGARGPHGGPSQPTG | 1206 | Q9UPA5 | |
| PAPRPRAHSCGGGGG | 121 | A6NLJ0 | |
| PGPKGEPGHRGTDGA | 276 | Q86Y22 | |
| GGLCSAAPGGGHPAP | 161 | P0CJ86 | |
| SPHTGAGPGALGPAL | 86 | Q8WY41 | |
| RPGAAGGGASAPGSP | 791 | O95206 | |
| GLRDAPVHGSPTGPG | 11 | Q9BRP1 | |
| QHGGQCRPSPGPGGG | 1256 | Q9UM47 | |
| GHRGDTGAQGLPGPP | 571 | P13942 | |
| PGPAGSPGERGAAGS | 1011 | P13942 | |
| PATTGDGGHSGLPPN | 1056 | Q8IWU2 | |
| PHPPRPGSGAAASGG | 291 | P54826 | |
| SGDGGPGTAPAPSHL | 46 | Q07075 | |
| GPGPGSGAHPGGSAR | 81 | Q8TAK6 | |
| PAPSPGGGDVSGQHG | 176 | Q9H0B6 | |
| GPGPGSALPARGHGQ | 66 | P09016 | |
| AAGSGPSPPGSPGHD | 41 | Q9BTU6 | |
| GLSSLGSGPGHPPSG | 106 | I0J062 | |
| GTGAPGHPQASPGAA | 336 | Q6PI47 | |
| AGPSGPAGKDGRTGH | 1056 | P08123 | |
| SRDASPGGPGGPGFA | 286 | Q8WXS5 | |
| GGPGSKEGPPRGNHA | 56 | Q92506 | |
| GGHLGPAGAAGPAPR | 921 | Q9P0X4 | |
| GGLCSAAPGGGHPAP | 161 | Q6RFH8 | |
| HGEPSHPPGGSGTES | 1046 | O75128 | |
| EHPGHPSGPRGSGGS | 516 | Q5T1N1 | |
| GSSGPTGPKGEAGHP | 1546 | P20908 | |
| HLGSRGFPGIPGPSG | 1106 | Q8IZC6 | |
| APGAAGNPGAPGHVG | 911 | Q8NFW1 | |
| GQPGDPGIPGHKGHT | 1411 | Q8NFW1 | |
| GGLCSAAPGGGHPAP | 161 | P0CJ90 | |
| GHPGAKGEPGSAGSP | 316 | Q9UEW3 | |
| PPAPGGGHGLSSGAA | 116 | Q5TF58 | |
| KGHRGFPGNPGAPGS | 1106 | P02461 | |
| ERGSEGSPGHPGQPG | 1171 | P02461 | |
| GGLCSAAPGGGHPAP | 161 | P0CJ88 | |
| NLDRSGPHGPGTSGG | 46 | Q14154 | |
| PPGHPPGSGGAESAD | 61 | Q9NSD7 | |
| PHGDESPRGSGGGGP | 496 | Q9Y6J9 | |
| GAHSPGATPGPGTAT | 36 | P17600 | |
| GGAGGPGASHLPPGA | 436 | P84550 | |
| SGAHGGRPGSAHSPP | 321 | A6NNA2 | |
| PGPEPGSERGHGGHG | 441 | A6NNA2 | |
| SPSPGAHGRRGGPEG | 471 | A6NNA2 | |
| HPGAGAGPGPGTDRS | 446 | Q16650 | |
| EAPRPGTHPSGGSGG | 381 | Q6ZMB5 | |
| PSSEHFPSPQGGGGG | 686 | Q8IXF0 | |
| GIPGTPGSHGLPGRD | 31 | Q8IWL1 | |
| RHGPGSGFPRGPGSG | 81 | E7EW31 | |
| PGSGHPGVAGNAPLG | 1066 | Q8TAQ2 | |
| GIPGTPGSHGLPGRD | 31 | Q8IWL2 | |
| GEPGGPGLPAHRTSS | 381 | Q7Z5H3 | |
| GLGHPASPGGSEDGP | 71 | Q99856 | |
| PGPGGGEHPTADRAG | 16 | Q86T13 | |
| THGKGGPAHSEGPGP | 371 | Q9Y3P4 | |
| GALREGHGGPLPSGP | 601 | Q9Y6X2 | |
| GGGGRGGLHDFRSPP | 21 | P23246 | |
| PAGPGGGSRSGSGRP | 36 | Q7RTU0 | |
| PSARTPGGGHSSGAP | 181 | O15417 | |
| SGPAGRGRGGEHGPQ | 231 | Q15654 | |
| EAGPAGGPSSAPGSH | 451 | O15062 | |
| PLLTHGPGPATSGGA | 121 | Q8WVR3 | |
| ATPGRGDTPGHATPG | 266 | O75533 | |
| GFIGGSSAEPGPGHP | 41 | Q8IV04 | |
| GGGGPPEPAGARAHS | 1426 | Q9P227 | |
| GNGSPGPGHGEPDVL | 96 | Q8WWA1 | |
| LAGPGSPSAGEHGPG | 2091 | Q5T1R4 | |
| SPSAGEHGPGLGLDP | 2096 | Q5T1R4 | |
| LSGTHGGSPGPERGG | 491 | Q8IV45 | |
| RTGSGGPGNHPHGPD | 481 | Q86UX7 | |
| GGPGGLGLPSHAARP | 126 | Q8NF64 | |
| SGGGAESLPPGGPGH | 636 | A8K0R7 | |
| PAKSPRGGPGSGGHG | 1096 | Q8N1G0 | |
| NGAGGPSGPGPEVHA | 361 | O60806 | |
| AGGRGSLHPAAGPGT | 36 | Q9H489 | |
| LSPPGSGPGSGSRHG | 26 | Q8N6N2 | |
| SGPGSGSRHGSARPG | 31 | Q8N6N2 | |
| GGSSPPAHPSLPGDG | 211 | Q14202 | |
| SGVPAAAHGAGGGPP | 191 | P50552 | |
| GGLCSAAPGGGHPAP | 161 | P0CJ85 | |
| LPHGGNSSAEGGRPG | 371 | Q6PJG9 | |
| ASPGASLGGPEGAHP | 111 | Q8TDC0 |